Skip to main content

Dr. Swarup Awarded Alzheimer’s Association Grant

By Carousel Slider, In the News
Dr. Vivek Swarup has been awarded an Alzheimer's Association Research Grant to study oligodendrocyte dysfunction in Alzheimer’s disease (AD). Dr. Swarup writes that Alzheimer’s disease has long been thought of as a problem of nerve cells, but new evidence shows that support cells called oligodendrocytes (OLs) may also play a direct role in driving the disease. These cells help insulate and protect nerves, but in Alzheimer’s, they appear to malfunction and may even produce harmful amyloid plaques. Our project will test how changes in a key regulator of OL affect its function and Alzheimer’s progression. By targeting OL dysfunction, we…
Read More

Dr. Karen Lincoln Appointed Co-Chair of New State Council on Toxic Substance Control

By Carousel Slider, In the News
The Department of Toxic Substances Control (DTSC) has appointed Dr. Karen Lincoln, a faculty member at UCI MIND, as a co-chair of its Environmental Justice Advisory Council (EJAC). This council is dedicated to protecting California communities that face disproportionate exposure to toxic substances. To read more about Dr. Lincoln’s appointment, click here.
Read More

UCI MIND researchers identify natural compounds to remove harmful proteins associated with Alzheimer’s disease

By Carousel Slider, In the News
UCI News highlighted a newly published study by Drs. Ricardo Santana (pictured left) and Gregory Brewer (pictured right)in the journal, GeroScience, in which they identified a combination of natural compounds that clear away harmful proteins associated with Alzheimer's disease. To read the UCI news article, click here.
Read More

UCI MIND Investigators Featured in UCI News for New Study on Sex Differences in AD Pathology Among Individuals with Down Syndrome

By Carousel Slider, In the News
Left to right: Elizabeth Andrews and Dr. Elizabeth Head UCI News highlighted a newly published study in Alzheimer's and Dementia led by Elizabeth Andrews, a PhD candidate in Dr. Elizabeth Head’s Lab, showing that women with Down syndrome may develop Alzheimer's disease more rapidly than men. To read the UCI news article, click here.
Read More

UCI MIND Trainees Recognized for Scientific Impact at AAIC

By Carousel Slider, In the News
At the recent Alzheimer’s Association International Conference (AAIC), thousands of posters were presented by investigators from around the world. The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) is a network of scientists, clinicians and dementia professionals who maintain Professional Interest Areas (PIAs). At AAIC, the leadership of the various PIAs selected trainees’ (graduate students and post-docs) poster for a competition in which the evaluation criteria was scientific impact. Remarkably, 3 UCI MIND trainees were selected. Paul Gaona-Partida (mentor Daniel Gillen) was selected for the Diversity and Disparities PIA for his poster “Assessing syndromic diagnosis and amyloid…
Read More

Dr. Lisi Flores-Aguilar wins the Postdoctoral Best Poster Award at AAIC

By Carousel Slider, In the News
Lisi Flores-Aguilar, PhD, a postdoctoral scholar in the Head Lab, was awarded with the Postdoctoral Best Poster Award for the Down Syndrome and Alzheimer's Disease Professional Interest Area (PIA) at this year's Alzheimer’s Association International Conference (AAIC). Her poster "Resilience to Alzheimer's disease in individuals with Down Syndrome” conveyed novel findings of her research. As a postdoctoral fellow in the lab of  Dr. Elizabeth Head, Dr. Lisi Flores-Aguilar studies cerebrovascular contributions to Alzheimer's diseases in individuals with Down syndrome using digital pathology.
Read More

UC Irvine expands national leadership in Alzheimer’s research with $21 million grant

By Carousel Slider, Commentary
With a $21 million renewal grant from the National Institute on Aging, the University of California, Irvine reinforces its status as a global leader in Alzheimer’s disease and related dementias research. The five-year award will support the continued work of UCI MIND’s Alzheimer’s Disease Research Center, which has been advancing understanding of memory impairments and engaging with the community for more than 40 years. “This funding comes at a crucial moment for our research,” said Joshua Grill, Ph.D., director of UCI MIND and co-director of the ADRC. “It will build on our history of discovery and propel translational dementia research…
Read More

UCI MIND Investigators Identify Differences in Cognitive Decline Based on Alzheimer’s Genes – by Casey Vanderlip

By Carousel Slider, In the News
Newly published research from UCI MIND scientists shows that people carrying a genetic risk factor (APOE4) for Alzheimer’s disease experience faster and more severe memory loss, but other cognitive abilities remain largely unchanged. The study, published in Neurology and led by MD/PhD student Casey Vanderlip and Professor Craig Stark in the Department of Neurobiology and Behavior, found that APOE4 specifically affects how and when memory declines in Alzheimer’s disease. While APOE4 is known to increase the likelihood of developing Alzheimer’s disease, this study shows that it also changes the rate of decline, speeding up memory loss while other cognitive abilities…
Read More

Drs. Head and Mapstone featured in AlzForum

By Carousel Slider, In the News
Two UCI MIND faculty members and principal investigators on the Alzheimer Biomarkers Consortium-Down Syndrome (ABC-DS) study have been featured this week in AlzForum for an article they co-authored in Lancet Neurology on June 12th about the ability of blood tests to predict dementia in people with Down syndrome.  Drs. Head and Mapstone also authored a response to the article in AlzForum which can be read here. The article in Lancet Neurology can be found by clicking here.
Read More